DC 欄位 | 值 | 語言 |
dc.contributor | 臺大公衛學院-預防醫學研究所;臺大醫院;臺大醫院-內科部;臺大醫院雲林分院;臺大醫學院; | en |
dc.contributor.author | CHIA-HSUIN CHANG | en_US |
dc.contributor.author | JOU-WEI LIN | en_US |
dc.contributor.author | Wu, Li-Chiu | en_US |
dc.contributor.author | Lai, Mei-Shu | en_US |
dc.contributor.author | LEE-MING CHUANG | en_US |
dc.creator | Chang, Chia-Hsuin;Lin, Jou-Wei;Wu, Li-Chiu;Lai, Mei-Shu;Chuang, Lee-Ming | en |
dc.creator | 賴美淑 ;張家勳 ;莊立民 ;林昭維 | zh-tw |
dc.date | 2012 | en |
dc.date.accessioned | 2014-02-14T04:44:00Z | - |
dc.date.accessioned | 2018-07-11T06:42:58Z | - |
dc.date.available | 2014-02-14T04:44:00Z | - |
dc.date.available | 2018-07-11T06:42:58Z | - |
dc.date.issued | 2012 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/258953 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw/bitstream/246246/258953/1/index.html | - |
dc.description.abstract | Background: Hyperinsulinemia might be the mechanism leading to an increased cancer risk in patients with type 2 diabetes. The objective was to evaluate the association between oral insulin secretagogues, insulins, and cancer incidence.
Methods: A total of 108,920 patients with newly diagnosed type 2 diabetes were identified from the Taiwan National Health Insurance claims database during the period from 1 January 2000 to 31 December 2000. As of 31 December 2007, patients with incident cancer were included as cases, and up to four age- and sex-matched controls were selected by risk-set sampling. Logistic regression models were applied to estimate the odds ratio (OR) and 95% confidence interval (CI) between antidiabetic medication and cancer incidence.
Results: A total of 8,194 incident cancer cases and 32,776 diabetic controls were included. A significantly increased risk for overall cancer incidence was found for any use of insulin (OR, 1.97; 95% CI, 1.85-2.09) and glinides (OR, 1.16; 95% CI, 1.06-1.28). Significantly increased risks were found for first-and second-generation sulfonylureas (OR, 1.08; 95% CI, 1.01-1.15), but not for third-generation drug, glimepiride (OR, 1.00; 95% CI, 0.93-1.08). Use of insulin and glinides was associated with higher risks for liver, colorectal, lung, stomach, and pancreas cancer, whereas sulfonylurea was mainly associated with an increased risk of liver cancer.
Conclusions: The results showed that sulfonylureas and glinides increased the risk for overall cancer, but to a lesser extent than insulin. Therapies that are associated with cancer risks certainly require further investigation. (J Clin Endocrinol Metab 97: E1170-E1175, 2012) | en_US |
dc.format.extent | 102 bytes | - |
dc.format.mimetype | text/html | - |
dc.language | en-us | en |
dc.relation | J. Clin. Endocrinol. Metab., 97(7), E1170-E1175 | en_US |
dc.relation.ispartof | The Journal of Clinical Endocrinology & Metabolism | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | 2,4 thiazolidinedione derivative; acetylsalicylic acid; alpha glucosidase inhibitor; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; glimepiride; hydroxymethylglutaryl coenzyme A reductase inhibitor; insulin; insulin derivative; metformin; oral antidiabetic agent; oral insulin secretagogue derivative; sulfonylurea derivative; unclassified drug; aged; article; cancer incidence; cancer patient; cancer risk; cohort analysis; colorectal cancer; controlled study; diabetic patient; female; high risk patient; human; liver cancer; longitudinal study; lung cancer; major clinical study; male; monotherapy; non insulin dependent diabetes mellitus; pancreas cancer; priority journal; risk assessment; stomach cancer; Administration, Oral; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Incidence; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Neoplasms; Registries; Risk Factors; Sulfonylurea Compounds | - |
dc.title | Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus | en_US |
dc.type | journal article | en_US |
dc.identifier.doi | 10.1210/jc.2012-1162 | - |
item.fulltext | with fulltext | - |
item.grantfulltext | open | - |
dc.relation.pages | E1170-E1175 | en_US |
dc.relation.journalvolume | 97 | en_US |
dc.relation.journalissue | 7 | en_US |
dc.identifier.uri.fulltext | http://ntur.lib.ntu.edu.tw/bitstream/246246/258953/1/index.html | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
item.fulltext | with fulltext | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0003-0024-6177 | - |
crisitem.author.orcid | 0000-0001-7614-3903 | - |
crisitem.author.orcid | 0000-0003-0978-2662 | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系
|